Drug Scheduling Fees
NDSAC and the national drug scheduling review process is funded on a cost-recovery basis.
For 2010, the cost of conducting a review of a submission is set at $42,000 (+GST).
In the event of more than one submission, the scheduling request sponsors will share the costs.
For further information about the fee structure, please contact NAPRA at 613-569-9658.
Back